KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,214,904 | +55.1% | 906,645 | +107.2% | 0.00% | – |
| Q2 2023 | $783,322 | +24.0% | 437,610 | +169.4% | 0.00% | – |
| Q1 2023 | $631,895 | -64.5% | 162,441 | -69.0% | 0.00% | -100.0% |
| Q4 2022 | $1,779,081 | +189.8% | 523,259 | +364.9% | 0.00% | – |
| Q3 2022 | $614,000 | -57.1% | 112,546 | -64.6% | 0.00% | -100.0% |
| Q2 2022 | $1,432,000 | -62.5% | 317,535 | -38.8% | 0.00% | 0.0% |
| Q1 2022 | $3,820,000 | +122.5% | 518,460 | +94.2% | 0.00% | – |
| Q4 2021 | $1,717,000 | -51.5% | 266,995 | -56.1% | 0.00% | -100.0% |
| Q3 2021 | $3,541,000 | +16.9% | 608,485 | +107.3% | 0.00% | 0.0% |
| Q2 2021 | $3,029,000 | +97.1% | 293,535 | +101.0% | 0.00% | 0.0% |
| Q1 2021 | $1,537,000 | +3.3% | 146,021 | +52.0% | 0.00% | – |
| Q4 2020 | $1,488,000 | -49.9% | 96,084 | -52.8% | 0.00% | -100.0% |
| Q3 2020 | $2,973,000 | +16.9% | 203,619 | +51.6% | 0.00% | 0.0% |
| Q2 2020 | $2,544,000 | +1704.3% | 134,318 | +1735.9% | 0.00% | – |
| Q1 2020 | $141,000 | -52.0% | 7,316 | -52.3% | 0.00% | – |
| Q4 2019 | $294,000 | -85.0% | 15,336 | -92.5% | 0.00% | -100.0% |
| Q3 2019 | $1,960,000 | +12150.0% | 203,742 | +7390.5% | 0.00% | – |
| Q2 2019 | $16,000 | 0.0% | 2,720 | 0.0% | 0.00% | – |
| Q1 2019 | $16,000 | -99.2% | 2,720 | -98.7% | 0.00% | -100.0% |
| Q4 2018 | $2,030,000 | +735.4% | 216,752 | +1416.1% | 0.00% | – |
| Q3 2018 | $243,000 | +49.1% | 14,297 | +49.4% | 0.00% | – |
| Q2 2018 | $163,000 | -38.3% | 9,567 | -51.3% | 0.00% | – |
| Q1 2018 | $264,000 | +1157.1% | 19,632 | +761.8% | 0.00% | – |
| Q4 2017 | $21,000 | -85.7% | 2,278 | -82.9% | 0.00% | – |
| Q3 2017 | $147,000 | +345.5% | 13,352 | +263.7% | 0.00% | – |
| Q2 2017 | $33,000 | +83.3% | 3,671 | +163.2% | 0.00% | – |
| Q1 2017 | $18,000 | -18.2% | 1,395 | -40.8% | 0.00% | – |
| Q4 2016 | $22,000 | -15.4% | 2,356 | -9.0% | 0.00% | – |
| Q3 2016 | $26,000 | +116.7% | 2,589 | +44.2% | 0.00% | – |
| Q2 2016 | $12,000 | -29.4% | 1,795 | -3.2% | 0.00% | – |
| Q1 2016 | $17,000 | -75.0% | 1,855 | -64.0% | 0.00% | – |
| Q4 2015 | $68,000 | +1260.0% | 5,158 | +997.4% | 0.00% | – |
| Q3 2015 | $5,000 | -88.4% | 470 | -70.2% | 0.00% | – |
| Q2 2015 | $43,000 | -98.4% | 1,579 | -98.2% | 0.00% | -100.0% |
| Q1 2015 | $2,701,000 | -61.1% | 88,242 | -52.5% | 0.00% | -60.0% |
| Q4 2014 | $6,952,000 | – | 185,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |